Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Labrie

Showing results (21-30 of 1,754) with videos related to

Pageof 176
Sort By:
Cancer|December 15, 1993
Mechanism of action and pure antiandrogenic properties of flutamideF Labrie
BJU International|June 28, 2007
Multiple intracrine hormonal targets in the prostate: opportunities and challengesFernand Labrie
Nature Reviews. Urology|December 10, 2014
Prostate cancer: Bicalutamide dose increase in castration-resistant diseaseFernand Labrie
Menopause (New York, N.Y.)|August 22, 2018
Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissuesFernand Labrie
Urology|September 25, 1997
Flutamide plus castration in patients with previously untreated prostate cancerF Labrie
Journal of Steroid Biochemistry|June 1, 1990
Derivatives of ethynylestradiol with oxygenated 17 alpha-alkyl side chain: synthesis and biological activityD Poirier, C Labrie, Y Mérand, et al.
DNA and Cell Biology|October 1, 1995
The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA speciesY Labrie, F Durocher, Y Lachance, et al.
Molecular and Cellular Endocrinology|February 8, 2003
Androgen blockade in prostate cancer in 2002: major benefits on survival in localized diseaseFernand Labrie
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 15, 2005
Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibilityFernand Labrie
Menopause (New York, N.Y.)|June 28, 2011
Impact of circulating dehydroepiandrosterone on androgen formation in womenFernand Labrie
Pageof 176

Showing results (21-30 of 1,754) with videos related to

Sort By:
Pageof 176
Cancer|December 15, 1993
Mechanism of action and pure antiandrogenic properties of flutamideF Labrie
BJU International|June 28, 2007
Multiple intracrine hormonal targets in the prostate: opportunities and challengesFernand Labrie
Nature Reviews. Urology|December 10, 2014
Prostate cancer: Bicalutamide dose increase in castration-resistant diseaseFernand Labrie
Menopause (New York, N.Y.)|August 22, 2018
Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissuesFernand Labrie
Urology|September 25, 1997
Flutamide plus castration in patients with previously untreated prostate cancerF Labrie
Journal of Steroid Biochemistry|June 1, 1990
Derivatives of ethynylestradiol with oxygenated 17 alpha-alkyl side chain: synthesis and biological activityD Poirier, C Labrie, Y Mérand, et al.
DNA and Cell Biology|October 1, 1995
The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA speciesY Labrie, F Durocher, Y Lachance, et al.
Molecular and Cellular Endocrinology|February 8, 2003
Androgen blockade in prostate cancer in 2002: major benefits on survival in localized diseaseFernand Labrie
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 15, 2005
Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibilityFernand Labrie
Menopause (New York, N.Y.)|June 28, 2011
Impact of circulating dehydroepiandrosterone on androgen formation in womenFernand Labrie
Pageof 176